American Pharmaceutical Security Act

This bill would require the head of the Centers for Medicare & Medicaid Services to send Congress a report within one year of the bill becoming law. The report would cover findings and recommendations on using Medicare and Medicaid coverage and payment powers to protect U.S. and allied markets for active pharmaceutical ingredients and key starting materials used to make drugs. It would also address reducing reliance on foreign adversaries for these materials. The report may recommend price floors to support U.S. manufacturing and giving priority to domestically made ingredients, and it must identify gaps in data about where these materials come from and who owns them.

Full text and official record on Congress.gov

Sponsors

• Adam B. Schiff Democrat sponsor
• 1 cosponsors